<DOC>
	<DOCNO>NCT00406822</DOCNO>
	<brief_summary>The purpose study determine whether OculusGen Collagen Matrix effective safe implant aid glaucoma surgery .</brief_summary>
	<brief_title>OculusGen-Glaucoma Historical Control Study Taiwan</brief_title>
	<detailed_description>OculusGen® Collagen Matrix porous , scaffold matrix . It implant top scleral flap beneath conjunctiva Tenon 's capsule end trabeculectomy . The pore scaffold matrix range 20 200µm , size suitable fibroblast grow randomly , body matrix without cause scar . The space occupy collagen matrix scaffold create room development filtration bleb . Immediately implantation , collagen matrix absorb aqueous humor bring certain pressure press top scleral flap make dynamic balance aqueous system keep IOP right side . The collagen matrix bio-degraded within 90 day leave physiologic space filtration bleb facilitate control intraocular pressure ( IOP ) .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Subject inclusion criterion : 1 . Age 18 year . 2 . At least one eye diagnose glaucoma receive maximally tolerate medical therapy . 3 . Subject able willing cooperate investigation plan . 4 . Subject able willing complete postoperative followup requirement . 5 . Subject willing sign inform consent form . Subject exclusion criterion : 1 . Have allergic reaction collagen 2 . Subject take anticoagulation and/or physician suggest stop take medication 3 . Normal tension glaucoma patient 4 . Subject one eye receive OculusGen™ implantation 5 . Subject diagnosed infection operation eye 6 . Subject anterior chamber abnormality 7 . Subject steroid glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>collagen matrix</keyword>
	<keyword>OculusGen</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>tissue engineering</keyword>
</DOC>